Market Place
Sourcing Support
Alpha Tau gets FDA approval for trial on recurrent glioblastoma
02 Apr 2025 //
GLOBENEWSWIRE
Alpha Tau announces 2024 financial results and corporate update
12 Mar 2025 //
GLOBENEWSWIRE
Alpha Tau to Participate in March Investor Conferences
27 Feb 2025 //
GLOBENEWSWIRE
Alpha Tau gets MDSAP certification
24 Feb 2025 //
GLOBENEWSWIRE
Alpha Tau Announces FDA IDE Approval for Pancreatic Cancer Trial
03 Feb 2025 //
GLOBENEWSWIRE
Alpha Tau To Share Interim Data Across Multiple Trials
27 Jan 2025 //
GLOBENEWSWIRE
Alpha Tau to Present Data at 2025 ASCO GI Symposium
18 Dec 2024 //
GLOBENEWSWIRE
Alpha Tau Appoints Maya Netser to Board, Meir Jakobsohn Steps Down
17 Dec 2024 //
GLOBENEWSWIRE
Alpha Tau to Present at 43rd Annual J.P. Morgan Health Conference
11 Dec 2024 //
GLOBENEWSWIRE
Alpha Tau to Attend Ladenburg’s Oncology Innovators Symposium
06 Dec 2024 //
GLOBENEWSWIRE
Alpha Tau Medical Announces Q3 2024 Financial Results & Update
19 Nov 2024 //
GLOBENEWSWIRE
Alpha Tau to Attend Citi & Piper Sandler Healthcare Conferences
13 Nov 2024 //
GLOBENEWSWIRE
Alpha Tau Accepted Into FDA’s Advisory For Alpha DaRT Access
21 Oct 2024 //
GLOBENEWSWIRE
Alpha Tau Treats First Patient with Recurrent Lung Cancer
10 Oct 2024 //
GLOBENEWSWIRE
FDA Approves Alpha Tau`s Alpha DaRT Study For cSCC
20 Sep 2024 //
GLOBENEWSWIRE
Alpha Tau To Participate In Multiple Investor Conferences
22 Aug 2024 //
GLOBENEWSWIRE
Alpha Tau Medical Announces Q2 2024 Financial Results And Corporate Update
14 Aug 2024 //
GLOBENEWSWIRE
Alpha Tau Publishes Long-Term Safety and Efficacy Data in Cancers Journal
25 Jun 2024 //
GLOBENEWSWIRE
Alpha Tau to Present at the Jefferies Global Healthcare Conference
21 May 2024 //
GLOBENEWSWIRE
Alpha Tau Medical Reports Q1 2024 Financials, Corporate Update
20 May 2024 //
GLOBENEWSWIRE
Alpha Tau Announces First Liver Metastases Patient Treated With Alpha DaRT
13 May 2024 //
GLOBENEWSWIRE
Alpha Tau Shows Pancreatic Cancer Abscopal Effect Preclinically
06 May 2024 //
GLOBENEWSWIRE
Alpha Tau to Participate in May Investor Conferences
01 May 2024 //
GLOBENEWSWIRE
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
25 Mar 2024 //
GLOBENEWSWIRE
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
26 Feb 2024 //
GLOBENEWSWIRE
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
20 Dec 2023 //
GLOBENEWSWIRE
Alpha Tau to Participate in Sidoti Small-Cap Conference
29 Nov 2023 //
GLOBENEWSWIRE
Alpha Tau Announces Promising Interim Results from Trial of Alpha DaRT Treatment
28 Nov 2023 //
GLOBENEWSWIRE
Alpha Tau to Participate in November Investor Conferences
01 Nov 2023 //
GLOBENEWSWIRE
Former Commissioner of FDA Stephen M. Hahn Appointed to Alpha Tau Advisory Board
24 Oct 2023 //
GLOBENEWSWIRE
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer
14 Sep 2023 //
GLOBENEWSWIRE
Alpha Tau Medical Announces 2Q 2023FYR and Provides Corporate Update
28 Aug 2023 //
GLOBENEWSWIRE
Alpha Tau Medical to Participate in September Investor Conferences
24 Aug 2023 //
GLOBENEWSWIRE
Alpha Tau Announces Long-Term Safety Data from Multiple Trials of Alpha DaRT
17 Aug 2023 //
GLOBENEWSWIRE
Alpha Tau Medical to Present at Emerging Growth Conference on August 9th, 2023
02 Aug 2023 //
GLOBENEWSWIRE
Alpha Tau Medical to Participate in June Investor Conferences
24 May 2023 //
GLOBENEWSWIRE
Alpha Tau Medical Announces First Quarter 2023 Financial Results
23 May 2023 //
GLOBENEWSWIRE
Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer
17 May 2023 //
GLOBENEWSWIRE
Alpha Tau Announces Publication of Multicenter Pilot Skin Cancer Trial Results
11 May 2023 //
GLOBENEWSWIRE
Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day
03 May 2023 //
GLOBENEWSWIRE
Alpha Tau and JGH Announce Alpha DaRT Treatment of Pancreatic Cancer Trial
03 Apr 2023 //
GLOBENEWSWIRE
Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit
29 Mar 2023 //
GLOBENEWSWIRE
Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley Bank
12 Mar 2023 //
GLOBENEWSWIRE
Alpha Tau Medical Announces Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Alpha Announces Grant of Radioactive License Approval at Jerusalem Headquarters
03 Mar 2023 //
GLOBENEWSWIRE
Alpha Tau to Participate in Citi 2023 Healthcare Services Conference
21 Feb 2023 //
GLOBENEWSWIRE
Alpha Tau to Present at Showcase & Participate in Corporate Access Event
13 Dec 2022 //
GLOBENEWSWIRE
Alpha Tau Medical Announces Third Quarter 2022 Financial Results
22 Nov 2022 //
GLOBENEWSWIRE
Alpha Tau Announces Multiple Corporate Updates Ahead of Annual Meeting
21 Oct 2022 //
GLOBENEWSWIRE
Alpha Tau Announces the Acceptance in Major Peer-Reviewed (International
08 Sep 2022 //
GLOBENEWSWIRE
Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer
01 Sep 2022 //
GLOBENEWSWIRE
Alpha Tau Medical Announces Second Quarter 2022 Financial Results
25 Aug 2022 //
GLOBENEWSWIRE
Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials
05 Jul 2022 //
GLOBENEWSWIRE
Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT™
22 Jun 2022 //
PRNEWSWIRE
Alpha Tau Announces Receipt of Radioactive License to Allow Production
16 Jun 2022 //
PRNEWSWIRE
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study
08 Jun 2022 //
PRNEWSWIRE
Alpha Tau Announces Resignation of Gary Leibler from its Board of Directors
07 Jun 2022 //
PRNEWSWIRE
Alpha Tau Medical Announces First Quarter 2022 Financial Results
26 May 2022 //
PRNEWSWIRE
First Alpha DaRT Patients Treated in France as Part of Alpha DaRT™ Multicenter Skin Cancer Trial
23 May 2022 //
PRESS RELEASE
Alpha Tau Medical Announces Full Year 2021 Financial Results
28 Mar 2022 //
PRNEWSWIRE
